University of Kansas Medical Center: NEJM Article Releases Positive Results Of Clinical Trial Investigating Treatment For Rare Inflammatory Disease, Dermatomyositis
November 23, 2022
November 23, 2022
KANSAS CITY, Kansas, Nov. 23 (TNSjou) -- The University of Kansas Medical Center issued the following news:
* * *
Mazen Dimachkie, M.D., was one of 36 researchers from Europe and North America to recruit participants for the first large-scale, randomized control study investigating intravenous immune globulin as a treatment for dermatomyositis.
* * *
Mazen Dimachkie, M.D., professor of neurology at the University of Kansas Medical Center, was a . . .
* * *
Mazen Dimachkie, M.D., was one of 36 researchers from Europe and North America to recruit participants for the first large-scale, randomized control study investigating intravenous immune globulin as a treatment for dermatomyositis.
* * *
Mazen Dimachkie, M.D., professor of neurology at the University of Kansas Medical Center, was a . . .